| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |